Search - tctmd.com

Displaying 481 - 500 of 659

Sort: Relevancy | Date

Presentation TCT 2015

Case 8: Successful OCT-Guided 2-Stent Treatment Using BRS

Presenter: Evald H. Christiansen, Andrejs Erglis, Maciej Lesiak

October 12, 2015

Presentation TCT 2015

Case 7: Procedural Issues and Early Healing Response After OCT-Guided Bifurcation Treatment Using BRS

Presenter: Evald H. Christiansen, Andrejs Erglis, Niels R. Holm

October 12, 2015

Presentation TCT 2015

Case 6: I Use OCT in (Almost) All Steps of BRS Treatment

Presenter: Evald H. Christiansen, Andrejs Erglis, Gustavs Latkovskis

October 12, 2015

Presentation TCT 2015

A Tribute to Liliana Grinfeld

Presenter: Dimitrios Alexopoulos, Roxana Mehran

October 12, 2015

News Industry News

Clinical Trial Demonstrates That A Bioresorbable Scaffold is Non-Inferior To A Drug-Eluting Stent In Chinese Patients With Coronary Artery Disease

October 12, 2015

News Conference News TCT 2015

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

Yael L. Maxwell

October 12, 2015

News Industry News

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

October 12, 2015

News Industry News

ABSORB II: Two-Year Data From The First Randomized Comparison Between Bioresorbable Vascular Scaffolds and Everolimus-Eluting Metallic Stents Show Comparable Patient Outcomes

October 12, 2015

News Conference News TCT 2015

Absorb BVS Matches Xience V in Chinese Patients

Todd Neale

October 12, 2015

Presentation TCT 2015

Debate: Will Bioresorbable Scaffolds Replace Metallic Stents in the Majority of Cases? NO!

Presenter: Carlo Di Mario, Eberhard Grube, Daniel I. Simon

October 11, 2015

Presentation TCT 2015

Debate: Will Bioresorbable Scaffolds Replace Metallic Stents in the Majority of Cases? YES!

Presenter: Carlo Di Mario, Eberhard Grube, Manel Sabate

October 11, 2015

Presentation TCT 2015

Case 2: A Case Where Metallic DES Was Preferred Over BVS

Presenter: Carlo Di Mario, Eberhard Grube, Nicolas M. Van Mieghem

October 11, 2015

Presentation TCT 2015

Case 1: A Case Where BVS Was Preferred Over Metallic DES

Presenter: Carlo Di Mario, Eberhard Grube, Azeem Latib

October 11, 2015

Presentation TCT 2015

Who Receives Bioresorbable Scaffolds in My Practice, and What Are My Tips and Tricks?

Presenter: Ricardo Lluberas, Roxana Mehran, Jamil Abdalla Saad, Roberto Botelho

October 11, 2015

Presentation TCT 2015

Bioresorbable Scaffolds in a Bifurcation During Primary PCI

Presenter: Mirvat Alasnag, Habib Gamra, Abdullah Shehab

October 11, 2015

Presentation TCT 2015

Role of Bioresorbable Vascular Scaffolds in a Hybrid Revascularization Strategy

Presenter: Taehoon Ahn, Robert C. Welsh, Quang Ngoc Nguyen

October 11, 2015

Presentation TCT 2015

Use of a Reentry Device for a Coronary CTO With Bioresorbable Scaffolds

Presenter: Mirvat Alasnag, Habib Gamra, Abdullah Shehab, Waqar H. Ahmed

October 11, 2015

Presentation TCT 2015

Bioresorbable Scaffolds in STEMI: Rationale and 1-Year TROFI II Results

Presenter: Dariusz Dudek, Robert J. de Winter, Patrick W. Serruys

October 11, 2015

Presentation TCT 2015

Poland Presents: The CTO Patient Polish Registry

Presenter: George D. Dangas, Eric Van Belle, Maciej Lesiak

October 11, 2015

Presentation TCT 2015

Germany Presents: The Diabetic Patient German Registry

Presenter: George D. Dangas, Eric Van Belle, Jens Wiebe

October 11, 2015

Advertisement

Case 8: Successful OCT-Guided 2-Stent Treatment Using BRS

Case 7: Procedural Issues and Early Healing Response After OCT-Guided Bifurcation Treatment Using BRS

Case 6: I Use OCT in (Almost) All Steps of BRS Treatment

A Tribute to Liliana Grinfeld

Clinical Trial Demonstrates That A Bioresorbable Scaffold is Non-Inferior To A Drug-Eluting Stent In Chinese Patients With Coronary Artery Disease

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

ABSORB II: Two-Year Data From The First Randomized Comparison Between Bioresorbable Vascular Scaffolds and Everolimus-Eluting Metallic Stents Show Comparable Patient Outcomes

Absorb BVS Matches Xience V in Chinese Patients

Debate: Will Bioresorbable Scaffolds Replace Metallic Stents in the Majority of Cases? NO!

Debate: Will Bioresorbable Scaffolds Replace Metallic Stents in the Majority of Cases? YES!

Case 2: A Case Where Metallic DES Was Preferred Over BVS

Case 1: A Case Where BVS Was Preferred Over Metallic DES

Who Receives Bioresorbable Scaffolds in My Practice, and What Are My Tips and Tricks?

Bioresorbable Scaffolds in a Bifurcation During Primary PCI

Role of Bioresorbable Vascular Scaffolds in a Hybrid Revascularization Strategy

Use of a Reentry Device for a Coronary CTO With Bioresorbable Scaffolds

Bioresorbable Scaffolds in STEMI: Rationale and 1-Year TROFI II Results

Poland Presents: The CTO Patient Polish Registry

Germany Presents: The Diabetic Patient German Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content